Log In
BCIQ
Print this Print this
 

Kanda HPV vaccine

  Manage Alerts
Collapse Summary General Information
Company Japan Health Sciences Foundation
Description 
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationHuman papillomavirus (HPV)
Indication DetailsTreat high-risk human papillomavirus (HPV) likely to cause cervical cancer
Regulatory Designation
PartnerKaketsuken

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/10/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today